Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0960
-0.0008 (-0.83%)
Nov 6, 2025, 12:01 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 117.85 million as of November 6, 2025. Its market cap has decreased by -53.17% in one year.
Market Cap
117.85M
Enterprise Value
135.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 117.85M, a decrease of -84.64%. That is a compound annual growth rate of -51.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 118.83M | -49.05% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.40T |
| Coloplast | 137.56B |
| Genmab | 116.25B |
| Demant | 48.14B |
| ALK-Abelló | 46.10B |
| H. Lundbeck | 43.61B |
| Zealand Pharma | 35.24B |
| Ambu A/S | 26.31B |